These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32400994)

  • 41. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.
    Fritz S; Sommer CM; Longerich T; Kuhn-Neureuther C; Radeleff B; Werner J; Hackert T
    Langenbecks Arch Surg; 2017 May; 402(3):465-473. PubMed ID: 28378237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of multi-electrode linear irreversible electroporation.
    Buist TJ; Groen MHA; Wittkampf FHM; Loh P; Doevendans PAFM; van Es R; Elvan A
    Europace; 2021 Mar; 23(3):464-468. PubMed ID: 33200191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility and effectiveness of endoscopic irreversible electroporation for the upper gastrointestinal tract: an experimental animal study.
    Jeon HJ; Choi HS; Keum B; Bang EJ; Lee KW; Kim SH; Yim SY; Lee JM; Kim ES; Seo YS; Jeen YT; Lee HS; Chun HJ; Kim HB; Kim JH
    Sci Rep; 2021 Jul; 11(1):15353. PubMed ID: 34321494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series.
    Agnass P; van Veldhuisen E; Vogel JA; Kok HP; de Keijzer MJ; Schooneveldt G; de Haan LR; Klaessens JH; Scheffer HJ; Meijerink MR; van Lienden KP; van Gulik TM; Heger M; Crezee J; Besselink MG
    J Clin Transl Res; 2020 Apr; 5(3):109-132. PubMed ID: 32617426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac impact of high-frequency irreversible electroporation using an asymmetrical waveform on liver in vivo.
    Li J; Wang J; Zhang X; Zhang X; Gao H; Xiao Y
    BMC Cardiovasc Disord; 2021 Dec; 21(1):581. PubMed ID: 34876030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technology of irreversible electroporation and review of its clinical data on liver cancers.
    Cohen EI; Field D; Lynskey GE; Kim AY
    Expert Rev Med Devices; 2018 Feb; 15(2):99-106. PubMed ID: 29307242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes.
    Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR
    Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irreversible electroporation: state of the art.
    Wagstaff PG; Buijs M; van den Bos W; de Bruin DM; Zondervan PJ; de la Rosette JJ; Laguna Pes MP
    Onco Targets Ther; 2016; 9():2437-46. PubMed ID: 27217767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Irreversible electroporation ablation: is all the damage nonthermal?
    Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
    Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of various types of US findings after irreversible electroporation in porcine liver: comparison with radiofrequency ablation.
    Sugimoto K; Moriyasu F; Kobayashi Y; Kasuya K; Nagakawa Y; Tsuchida A; Hara T; Iobe H; Oshiro H
    J Vasc Interv Radiol; 2015 Feb; 26(2):279-87.e3. PubMed ID: 25645416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Safety of Irreversible Electroporation on Nerves Adjacent to Treated Tumors.
    Luo X; Qin Z; Tao H; Shi J; Fang G; Li Z; Zhou X; Chen J; Xu K; Zeng J; Niu L
    World Neurosurg; 2017 Dec; 108():642-649. PubMed ID: 28927918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
    Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ
    BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the irreversible electroporation in the hepato-pancreatico-biliary surgery.
    Sánchez-Velázquez P; Clavien PA
    Cir Esp; 2017; 95(6):307-312. PubMed ID: 28318494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
    Zhang B; Yang Y; Ding L; Moser MAJ; Zhang EM; Zhang W
    Ann Biomed Eng; 2019 Mar; 47(3):694-705. PubMed ID: 30565007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study.
    Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
    Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
    Front Immunol; 2021; 12():811726. PubMed ID: 35069599
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pain After Percutaneous Irreversible Electroporation of Renal Tumors Is Not Dependent on Tumor Location.
    Sorokin I; Lay AH; Reddy NK; Canvasser NE; Chamarthy M; Cadeddu JA
    J Endourol; 2017 Aug; 31(8):751-755. PubMed ID: 28586250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of (sub-)acute cerebral events or lesions after electroporation ablation in the left-sided canine heart.
    Neven K; Füting A; Byrd I; Heil RW; Fish JM; Feeney DA; Donskoy E; Jensen JA
    Heart Rhythm; 2021 Jun; 18(6):1004-1011. PubMed ID: 33617997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.